Table 1.
Clinicopathological characteristics of TNBC patients in this study.
| Data set | TCGA_TNBC | GEOD 40525 data set |
|---|---|---|
| Number | ||
| TNBC | 117 | 8 |
| Adjacent normal | 8 | 7 |
| Total | 125 | 15 |
| Age (years) | 57.42±14.56 | NA |
| Preservation type | Fresh tissue | Fresh tissue |
| TNM Stage | ||
| I | 21 | NA |
| II | 68 | NA |
| III | 21 | NA |
| IV | 1 | NA |
| Other | 6 | NA |
| Lymph node metastasis | ||
| Present | 74 | 5 |
| Absent | 37 | 3 |
| Other | 6 | 0 |
| Distant metastasis | ||
| Present | 4 | NA |
| Absent | 107 | NA |
| Other | 6 | NA |
| Number of deaths | 96 | NA |
| Median survival (months) | 25.4 | NA |
| Follow-up period (days) | ||
| Median | 858 | NA |
| Range | 1-3472 | NA |
| Platform | Illumina HiSeq 2000 miRNA Sequencing, Illumina Genome Analyzer miRNA Sequencing | Agilent 019118 Human miRNA Microarray 2.0 |
NA: not available. Mean ± standard deviation (SD) were presented.